Gene · 1213
Papers3,108
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,108
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid-anchored proteasomes control membrane protein homeostasis. | Sci Adv | 2023 | 38019907 | PubTator, text mining | PubMed |
| A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers. | Int J Mol Sci | 2023 | 38003247 | PubTator, text mining | PubMed |
| Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents. | Mol Pharm | 2023 | 37963105 | PubTator, text mining | PubMed |
| Crizotinib combined with bronchoscopic interventional treatment in ALK-positive inflammatory myofibroblastic tumor of left main stem bronchus: a case report. | J Cardiothorac Surg | 2023 | 37950305 | PubTator, text mining | PubMed |
| Synaptic Involvement of the Human Amygdala in Parkinson's Disease. | Mol Cell Proteomics | 2023 | 37947401 | PubTator, text mining | PubMed |
| The Salmonella Typhimurium Effector SpvB Subverts Host Membrane Trafficking by Targeting Clathrin and AP-1. | Mol Cell Proteomics | 2023 | 37924977 | PubTator, text mining | PubMed |
| To investigate the mechanism of Yiwei Decoction in the treatment of premature ovarian insufficiency-related osteoporosis using transcriptomics, network pharmacology and molecular docking techniques. | Sci Rep | 2023 | 37923747 | PubTator, text mining | PubMed |
| Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing. | Cancer Biol Ther | 2023 | 37906510 | PubTator, text mining | PubMed |
| Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells. | Pharmaceutics | 2023 | 37896219 | PubTator, text mining | PubMed |
| Recent Computational Advances Regarding Amyloid-β and Tau Membrane Interactions in Alzheimer's Disease. | Molecules | 2023 | 37894559 | PubTator, text mining | PubMed |
| Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion. | Front Oncol | 2023 | 37869075 | PubTator, text mining | PubMed |
| Different seminal ejaculated fractions in artificial insemination condition the protein cargo of oviductal and uterine extracellular vesicles in pig. | Front Cell Dev Biol | 2023 | 37868907 | PubTator, text mining | PubMed |
| Proposal of neural network model for neurocognitive rehabilitation and its comparison with fuzzy expert system model. | BMC Med Inform Decis Mak | 2023 | 37845677 | PubTator, text mining | PubMed |
| Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma. | Biochem Biophys Res Commun | 2023 | 37844446 | PubTator, text mining | PubMed |
| PITX1 plays essential functions in cancer. | Front Oncol | 2023 | 37841446 | PubTator, text mining | PubMed |
| Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review. | Front Oncol | 2023 | 37841422 | PubTator, text mining | PubMed |
| Hyperinsulinemia Impairs Clathrin-Mediated Endocytosis of the Insulin Receptor and Activation of Endothelial Nitric Oxide Synthase in Brain Endothelial Cells. | Int J Mol Sci | 2023 | 37834116 | PubTator, text mining | PubMed |
| Single-cell DNA methylation and 3D genome architecture in the human brain. | Science | 2023 | 37824674 | PubTator, text mining | PubMed |
| Federated machine learning for predicting acute kidney injury in critically ill patients: a multicenter study in Taiwan. | Health Inf Sci Syst | 2023 | 37822805 | PubTator, text mining | PubMed |
| Adaptive radiotherapy of locally advanced sigmoid colon cancer with intra‑fractional motion using the MRIdian system: A case report. | Oncol Lett | 2023 | 37818131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/papers?page=8